Biosynthetic Technologies acquires Innoleo

Indianapolis-based Biosynthetic Technologies, which makes synthetic compounds called estolides from organic fatty acids found in various bio-derived oils, has acquired Innoleo, a specialist in castor oil and derivatives located in Ohio.

The products of both companies have applications in multiple industries, including personal care.

“The unique structure of castor oil offers interesting properties, making it appropriate for various industrial applications,” said Mark Miller, CEO at Biosynthetic Technologies. In particular, he noted, it is high in ricinoleic acid, making it suitable in a wide variety of applications, including personal care.

Latest Issues

Society of Cosmetic Chemists 78th Annual Scientific Meeting & Showcase

JW Marriot Los Angeles L.A. LIVE
11th - 13th December 2024

PCHi 2025

China Import and Export Fair Complex Guangzhou
19-21 February 2025